HK48590A - NOVEL 8α-ACYLAMINOERGOLINES - Google Patents

NOVEL 8α-ACYLAMINOERGOLINES Download PDF

Info

Publication number
HK48590A
HK48590A HK485/90A HK48590A HK48590A HK 48590 A HK48590 A HK 48590A HK 485/90 A HK485/90 A HK 485/90A HK 48590 A HK48590 A HK 48590A HK 48590 A HK48590 A HK 48590A
Authority
HK
Hong Kong
Prior art keywords
hydrogen
acylaminoergolines
novel
5alkenyl
7alkyl
Prior art date
Application number
HK485/90A
Other languages
English (en)
Inventor
Haefliger Walter
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK48590A publication Critical patent/HK48590A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK485/90A 1984-01-12 1990-06-21 NOVEL 8α-ACYLAMINOERGOLINES HK48590A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3400853 1984-01-12

Publications (1)

Publication Number Publication Date
HK48590A true HK48590A (en) 1990-06-29

Family

ID=6224786

Family Applications (1)

Application Number Title Priority Date Filing Date
HK485/90A HK48590A (en) 1984-01-12 1990-06-21 NOVEL 8α-ACYLAMINOERGOLINES

Country Status (28)

Country Link
US (2) US4950672A (enExample)
JP (1) JPH0655739B2 (enExample)
AT (1) AT391317B (enExample)
AU (3) AU583489B2 (enExample)
BE (1) BE901456A (enExample)
CA (1) CA1245640A (enExample)
CH (1) CH664568A5 (enExample)
CY (1) CY1542A (enExample)
DE (1) DE3500251C2 (enExample)
DK (1) DK169891B1 (enExample)
ES (1) ES8605514A1 (enExample)
FI (1) FI82466C (enExample)
FR (1) FR2560196B1 (enExample)
GB (1) GB2152507B (enExample)
GR (1) GR850065B (enExample)
HK (1) HK48590A (enExample)
HU (1) HU197569B (enExample)
IE (1) IE58228B1 (enExample)
IL (1) IL74043A (enExample)
IT (1) IT1214648B (enExample)
LU (1) LU85725A1 (enExample)
NL (1) NL193541C (enExample)
NZ (1) NZ210818A (enExample)
PH (1) PH23286A (enExample)
PT (1) PT79818B (enExample)
SE (1) SE460420B (enExample)
SG (1) SG32390G (enExample)
ZA (1) ZA85276B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664568A5 (de) * 1984-01-12 1988-03-15 Sandoz Ag 8-alpha-acylaminoergoline.
ATE107647T1 (de) * 1984-04-09 1994-07-15 Schering Ag 2-substituierte ergolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
NL8700046A (nl) * 1986-01-24 1987-08-17 Sandoz Ag 8 alfa-acylaminoergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
US4931447A (en) * 1987-06-15 1990-06-05 Eli Lilly And Company Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
US4981859A (en) * 1987-06-15 1991-01-01 Cycloalkylamides of (8 beta )-1-alkyl-6-(substituted)ergolines
DE3820159A1 (de) * 1987-06-23 1989-01-05 Sandoz Ag 8(alpha)-acylaminoergolin, seine herstellung und dieses enthaltende arzneimittel
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
GB8824744D0 (en) * 1988-10-21 1988-11-30 Erba Carlo Spa Antiemesis ergoline derivatives
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
BR112017015510A2 (pt) * 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo
CN113149982A (zh) 2015-01-20 2021-07-23 Xoc制药股份有限公司 麦角灵化合物及其用途
JP2020522504A (ja) 2017-06-01 2020-07-30 エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ 多環式化合物およびそれらの用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218323A (en) * 1965-11-16 Esters of i,g-dimethyl-b-ergolenyl carbamic acid
US2864822A (en) * 1956-10-22 1958-12-16 Lilly Co Eli 9-amino-7-methyl-belta10-ergolene and derivatives thereof
CH622519A5 (en) * 1974-07-05 1981-04-15 Hoechst Ag Process for the preparation of hydroxyalkylxanthines
GB1517971A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 8alpha-substituted ergoline i derivatives
US4348392A (en) * 1974-07-19 1982-09-07 Sandoz Ltd. 8α-Substituted ergoline-I derivatives
US3922347A (en) * 1974-12-19 1975-11-25 Lilly Co Eli Method of inhibiting prolactin secretion with 8-acylaminoergolenes
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
CH622518A5 (en) * 1976-12-14 1981-04-15 Sandoz Ag Process for the preparation of novel ergoline compounds
CH644606A5 (de) * 1980-09-23 1984-08-15 Sandoz Ag Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
CH664568A5 (de) * 1984-01-12 1988-03-15 Sandoz Ag 8-alpha-acylaminoergoline.
HU195810B (en) * 1984-12-24 1988-07-28 Sandoz Ag Process for preparing new 8alpha-acyl-amino-ergoline derivatives and pharmaceutical compositions containing such compounds
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto

Also Published As

Publication number Publication date
GB2152507B (en) 1987-07-15
DE3500251A1 (de) 1985-07-18
ES8605514A1 (es) 1986-03-16
US4950672A (en) 1990-08-21
IT1214648B (it) 1990-01-18
ZA85276B (en) 1986-08-27
IT8547538A0 (it) 1985-01-11
GB8500454D0 (en) 1985-02-13
ES539511A0 (es) 1986-03-16
GR850065B (enExample) 1985-05-03
AU2506688A (en) 1989-02-23
US5077298A (en) 1991-12-31
SE8500107L (sv) 1985-07-13
JPH0655739B2 (ja) 1994-07-27
JPS60174783A (ja) 1985-09-09
FI850130L (fi) 1985-07-13
ATA5985A (de) 1990-03-15
PT79818B (en) 1987-01-07
GB2152507A (en) 1985-08-07
NZ210818A (en) 1989-02-24
AU618290B2 (en) 1991-12-19
HUT37148A (en) 1985-11-28
CA1245640A (en) 1988-11-29
AU3760985A (en) 1985-07-18
CY1542A (en) 1991-03-22
PT79818A (en) 1985-02-01
FI82466C (fi) 1991-03-11
DK12685A (da) 1985-07-13
SE460420B (sv) 1989-10-09
FI82466B (fi) 1990-11-30
IL74043A (en) 1988-10-31
DK12685D0 (da) 1985-01-10
HU197569B (en) 1989-04-28
DK169891B1 (da) 1995-03-27
AU2506788A (en) 1989-03-02
IL74043A0 (en) 1985-04-30
NL8500008A (nl) 1985-08-01
BE901456A (fr) 1985-07-08
AU609539B2 (en) 1991-05-02
AT391317B (de) 1990-09-25
PH23286A (en) 1989-06-30
SE8500107D0 (sv) 1985-01-10
LU85725A1 (fr) 1985-10-22
FR2560196B1 (fr) 1986-07-18
IE58228B1 (en) 1993-08-11
CH664568A5 (de) 1988-03-15
IE850064L (en) 1985-07-12
SG32390G (en) 1990-08-03
NL193541C (nl) 2000-01-04
NL193541B (nl) 1999-09-01
FI850130A0 (fi) 1985-01-11
DE3500251C2 (de) 1995-01-26
FR2560196A1 (fr) 1985-08-30
AU583489B2 (en) 1989-05-04

Similar Documents

Publication Publication Date Title
GR3007513T3 (enExample)
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
IT8521213A0 (it) Composizioni covulcanizzabili di fluoroelastomeri a migliorata stabilita' chimica.
CA2243504A1 (en) New 19-nor-pregnene derivatives
SE8500107L (sv) Nya 8-alfa-acylaminoergoline
IE851734L (en) Isoindolinyl-alkyl-piperazines
ES8605510A1 (es) Procedimiento para preparar derivados de bencilftalazinona sustituidos
CA2024162A1 (en) Benzazabicyclo carbamates as novel cholinesterase inhibitors
ATE30429T1 (de) Acylamino-oxo- oder hydroxy-substituiertealkylamino thiazine und thiazepine.
IE791943L (en) Phenyl quinolizidines.
ZA9410287B (en) N-oxides of 4-arylpiperazines and 4-arylpiperidines
ATE232732T1 (de) 2',5'-phosphorthioat/phosphodiester- oligoadenylate und ihre antiviralen verwendungen
IE791552L (en) 1,2-disubstituted imidazolines
SE8506125L (sv) 8alfa-acylaminoergoliner, deras framstellning och farmaceutiska kopositioner innehallande dessa
EP0207606A3 (en) Use of pinacidil as an antiasthma agent
DE59109029D1 (de) 3-substituierte Cephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
IE780262L (en) Carbocyclic fused thiophen-2-oxaminic acid derivatives
AU553493B2 (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives
DE59405727D1 (de) Thiocarbamoylverbindungen als mikrobizide
ES8707212A1 (es) Procedimiento para preparar dihidro-1,4-tiazinas aroil-sustituidas
AU9084091A (en) 3-{2-chloro-4-(trifluoromethyl)phenoxy}-1-azetidine carboxamides having anticonvulsant activity
ZA906445B (en) New 1,3-oxazines
UA46181A1 (uk) Похідні 4-метил-5-нітроакридину, який має антимікробну та жовчогонну активність
IL76936A (en) 3-amino-2,3-dihydro-1-benzoxepine compounds,their preparation and pharmaceutical compositions containing them
ITMI931728A1 (it) Composti eterociclici ad attivita' cardiovascolare

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)